Acic Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company.
One of their notable products is CYSTEAMINE BITARTRATE, with a corresponding US DMF Number 26816.
Remarkably, this DMF maintains an Active status since its submission on September 05, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 26, 2015, and payment made on September 06, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II